59 research outputs found
Expression of Werner and Bloom syndrome genes is differentially regulated by in vitro HIV-1 infection of peripheral blood mononuclear cells
In HIV infection, continuous immune activation leads to accelerated ageing of the adaptive immune system, similar to that observed in elderly people. We investigated the expression of WRN and BLM (genes involved in disorders characterized by premature ageing, genomic instability and cancer predisposition) in peripheral blood mononuclear cells (PBMC) activated in vitro with phytohaemagglutinin (PHA) and infected with different HIV-1 strains. The steady state levels of mRNA were analysed by reverse transcription-polymerase chain reaction (RT-PCR), and protein expression was assayed using immunocytochemistry and Western blot techniques. In uninfected PBMC, PHA stimulation induced an increase in BLM mRNA and protein expression, while WRN expression remained virtually unchanged. When PBMC were infected in vitro with a lymphotropic HIV-1 strain, the level of BLM mRNA showed a peak at 24 h of infection, followed by a decline to uninfected culture levels. A similar result failed to be seen using an R5-tropic HIV-1 strain. In accordance with mRNA expression, in HIV-infected cultures PBMC were stained more frequently and more intensely by a BLM-specific antibody as compared to uninfected cultures, staining peaking at 24. Conversely, WRN expression was not modulated by HIV-1. The proportion of cells showing BLM up-regulation, established by immunocytochemical staining, was much greater than the proportion of productively infected PBMC, as established by proviral DNA measurement. This result indicates that BLM up-regulation is probably a result of an indirect bystander cell effect. Activation of the BLM gene in infected PBMC suggests that premature ageing could be a further immunopathogenetic mechanism involved in HIV-induced immunodeficiency, and points to a possible new candidate target for innovative therapeutic intervention
Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
Analysis of Secreted Proteins from Prepubertal Ovarian Tissues Exposed In Vitro to Cisplatin and LH
It is well known that secreted and exosomal proteins are associated with a broad range of physiological processes involving tissue homeostasis and differentiation. In the present paper, our purpose was to characterize the proteome of the culture medium in which the oocytes within the primordial/primary follicles underwent apoptosis induced by cisplatin (CIS) or were, for the most part, protected by LH against the drug. To this aim, prepubertal ovarian tissues were cultured under control and in the presence of CIS, LH, and CIS + LH. The culture media were harvested after 2, 12, and 24 h from chemotherapeutic drug treatment and analyzed by liquid chromatographyâmass spectrometry (LC-MS). We found that apoptotic conditions generated by CIS in the cultured ovarian tissues and/or oocytes are reflected in distinct changes in the extracellular microenvironment in which they were cultured. These changes became evident mainly from 12 h onwards and were characterized by the inhibition or decreased release of a variety of compounds, such as the proteases Htra1 and Prss23, the antioxidants Prdx2 and Hbat1, the metabolic regulators Ldha and Pkm, and regulators of apoptotic pathways such as Tmsb4x. Altogether, these results confirm the biological relevance of the LH action on prepuberal ovaries and provide novel information about the proteins released by the ovarian tissues exposed to CIS and LH in the surrounding microenvironment. These data might represent a valuable resource for future studies aimed to clarify the effects and identify biomarkers of these compoundsâ action on the developing ovary
Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75
Transglutaminase type 2 (TG2) is a multifunctional enzyme that plays a key role in mitochondria homeostasis under stressful cellular conditions. TG2 interactome analysis reveals an enzyme interaction with GRP75 (glucose-regulated protein 75). GRP75 localizes in mitochondria-associated membranes (MAMs) and acts as a bridging molecule between the two organelles by assembling the IP3R-GRP75-VDAC complex, which is involved in the transport of Ca2+ from the endoplasmic reticulum (ER) to mitochondria. We demonstrate that the TG2 and GRP75 interaction occurs in MAMs. The absence of the TG2-GRP75 interaction leads to an increase of the interaction between IP3R-3 and GRP75; a decrease of the number of ER-mitochondria contact sites; an impairment of the ER-mitochondrial Ca2+ flux; and an altered profile of the MAM proteome. These findings indicate TG2 is a key regulatory element of the MAMs
High levels of trim5a are associated with xenophagy in hivâ1âinfected longâterm nonprogressors
Autophagy is a lysosomalâdependent degradative mechanism essential in maintaining cellular homeostasis, but it is also considered an ancient form of innate eukaryotic fighting against invading microorganisms. Mounting evidence has shown that HIVâ1 is a critical target of autoph-agy that plays a role in HIVâ1 replication and disease progression. In a special subset of HIVâ1âinfected patients that spontaneously and durably maintain extremely low viral replication, namely, longâterm nonprogressors (LTNP), the resistance to HIVâ1âinduced pathogenesis is ac-companied, in vivo, by a significant increase in the autophagic activity in peripheral blood mon-onuclear cells. Recently, a new player in the battle of autophagy against HIVâ1 has been identified, namely, tripartite motif protein 5α (TRIM5α). In vitro data demonstrated that TRIM5α directly recognizes HIVâ1 and targets it for autophagic destruction, thus protecting cells against HIVâ1 in-fection. In this paper, we analyzed the involvement of this factor in the control of HIVâ1 infection through autophagy, in vivo, in LTNP. The results obtained showed significantly higher levels of TRIM5α expression in cells from LTNP with respect to HIVâ1âinfected normal progressor patients. Interestingly, the colocalization of TRIM5α and HIVâ1 proteins in autophagic vacuoles in LTNP cells suggested the participation of TRIM5α in the autophagy containment of HIVâ1 in LTNP. Al-together, our results point to a protective role of TRIM5α in the successful control of the chronic viral infection in HIVâ1âcontrollers through the autophagy mechanism. In our opinion, these findings could be relevant in fighting against HIVâ1 disease, because autophagy inducers might be employed in combination with antiretroviral drugs
Intracellular expression of Tat alters mitochondrial functions in T cells: a potential mechanism to understand mitochondrial damage during HIV-1 replication
HIV-1 replication results in mitochondrial damage that is enhanced during antiretroviral therapy (ART).
The onset of HIV-1 replication is regulated by viral protein Tat, a 101-residue protein codified by two exons that elongates viral transcripts. Although the first exon of Tat (aa 1â72) forms itself an active protein, the presence of the second exon (aa 73â101) results in a more competent transcriptional protein with additional functions.
Results: Mitochondrial overall functions were analyzed in Jurkat cells stably expressing full-length Tat (Tat101) or one-exon Tat (Tat72). Representative results were confirmed in PBLs transiently expressing Tat101 and in HIV-infected Jurkat cells. The intracellular expression of Tat101 induced the deregulation of metabolism and cytoskeletal proteins which remodeled the function and distribution of mitochondria. Tat101 reduced the transcription of the mtDNA,
resulting in low ATP production. The total amount of mitochondria increased likely to counteract their functional impairment. These effects were enhanced when Tat second exon was expressed.
Conclusions: Intracellular Tat altered mtDNA transcription, mitochondrial content and distribution in CD4+ T cells.
The importance of Tat second exon in non-transcriptional functions was confirmed. Tat101 may be responsible for mitochondrial dysfunctions found in HIV-1 infected patients.We greatly appreciate the secretarial assistance of Mrs Olga Palao. This work was supported by FIPSE (360924/10), Spanish Ministry of Economy and Competitiveness (SAF2010-18388), Spanish Ministry of Health (EC11- 285), AIDS Network ISCIII-RETIC (RD12/0017/0015), Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness (FIS PI12/00506). The work of Sara RodrĂguez-Mora is supported by a fellowship of Sara Borrell from Spanish Ministry of Economy and Competitiveness (2013). The work of MarĂa Rosa LĂłpez-Huertas is supported by a fellowship of the European Union Programme Health 2009 (CHAARM).S
Il ciclo litico di EBV e la risposta autofagica in cellule di linfoma di Burkitt
IL CICLO LITICO DI EBV E LA RISPOSTA AUTOFAGICA IN CELLULE DI LINFOMA DI BURKITT
Francesca Colavita, Alessandra De Leo, Fabiola Ciccosanti, Gian Maria Fimia, Elena Mattia
Dip. di Scienze di SanitĂ Pubblica e Malattie Infettive âSanarelliâ, Univ. di Roma âSapienzaâ
Laboratorio di Biologia Cellulare, Istituto Nazionale per le malattie infettive IRCCS âL. Spallanzaniâ, Roma
Il pathway autofagico Ăš coinvolto in numerosi processi cellulari e rappresenta un essenziale meccanismo di difesa contro le infezioni virali. Numerosi virus per sopravvivere e propagarsi allâinterno dellâospite hanno evoluto strategie in grado di evadere e di modulare la risposta autofagica a proprio vantaggio.
Il virus di Epstein Barr (EBV), un Îł-herpesvirus umano responsabile della mononucleosi infettiva ed associato a differenti tipi di neoplasie di origine epiteliale e linfoide, Ăš caratterizzato da una infezione latente e una litica produttiva.
Al momento non ci sono informazioni su eventuali alterazioni del pathway autofagico durante il ciclo litico del virus. Scopo di questo lavoro Ăš stato pertanto quello di analizzare lâespressione di proteine markers di autofagia a seguito della induzione del ciclo replicativo attivo di EBV e dâaltro canto, di valutare lâeffetto di inibitori e promotori di autofagia sulla espressione e sulla replicazione del virus. Sono stati utilizzati due modelli cellulari di linfoma di Burkitt, le cellule Akata e Mutu, in cui il ciclo litico di EBV puĂČ essere innescato mediante trattamento delle cellule, rispettivamente con IgG o con TGF ÎČ.
I risultati ottenuti dimostrano che lâattivazione della replicazione virale in cellule B infettate dal virus in forma latente, determina a tempi brevi, un aumento della componente LC3 II e della proteina p62, indici della formazione di vescicole autofagiche. Inoltre, la presenza di inibitori di autofagia quali la Bafilomicina A1 e la Spautina-1 durante lâinduzione del ciclo litico di EBV provoca una sovra-regolazione dellâespressione dei geni litici e un aumento delle particelle virali prodotte.
Tali dati, indicano che il ciclo replicativo attivo di EBV Ăš contrastato dal processo autofagico e che una inibizione di questâultimo, in due diversi steps del pathway degradativo, genera un aumento della espressione e della replicazione del virus. In accordo con questi risultati, cellule Akata in cui beclina-1, la proteina che innesca la risposta autofagica, Ăš stata silenziata mediante trasfezione con lentivirus, hanno mostrato un aumento significativo dellâespressione degli antigeni virali litici rispetto alle cellule trasfettate con la sequenza âscrambledâ.
Sono in corso studi atti a valutare la possibilitĂ che EBV interferisca e moduli la risposta autofagica durante il ciclo litico
Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases
Alzheimer's, Parkinson's and Huntington's disease, and amyotrophic lateral sclerosis are the most relevant neurodegenerative syndromes worldwide. The identification of the etiology and additional factors contributing to the onset and progression of these diseases is of great importance in order to develop both preventive and therapeutic intervention. A common feature of these pathologies is the formation of aggregates, containing mutated and/or misfolded proteins, in specific subsets of neurons, which progressively undergo functional impairment and die. The relationship between protein aggregation and the molecular events leading to neurodegeneration has not yet been clarified. In the last decade, several lines of evidence pointed to a major role for mitochondrial dysfunction in the onset of these pathologies. Here, we review how proteomics has been applied to neurodegenerative diseases in order to characterize the relationship existing between protein aggregation and mitochondrial alterations. Moreover, we highlight recent advances in the use of proteomics to identify protein modifications caused by oxidative stress. Future developments in this field are expected to significantly contribute to the full comprehension of the molecular mechanisms at the heart of neurodegeneration
Mitochondrial Interactome: A Focus on Antiviral Signaling Pathways
In the last years, proteomics has represented a valuable approach to elucidate key aspects in the regulation of type I/III interferons (IFNs) and autophagy, two main processes involved in the response to viral infection, to unveil the molecular strategies that viruses have evolved to counteract these processes. Besides their main metabolic roles, mitochondria are well recognized as pivotal organelles in controlling signaling pathways essential to restrain viral infections. In particular, a major role in antiviral defense is played by mitochondrial antiviral signaling (MAVS) protein, an adaptor protein that coordinates the activation of IFN inducing pathways and autophagy at the mitochondrial level. Here, we provide an overview of how mass spectrometry-based studies of proteinâprotein interactions and post-translational modifications (PTMs) have fostered our understanding of the molecular mechanisms that control the mitochondria-mediated antiviral immunity. © Copyright © 2020 Refolo, Vescovo, Piacentini, Fimia and Ciccosanti
- âŠ